Characterization of sequence determinants of enhancer function using natural genetic variation

  1. Marty G Yang
  2. Emi Ling
  3. Christopher J Cowley
  4. Michael E Greenberg  Is a corresponding author
  5. Thomas Vierbuchen  Is a corresponding author
  1. Harvard University, United States
  2. Rockefeller University, Howard Hughes Medical Institute, United States
  3. Memorial Sloan Kettering Cancer Center, United States

Abstract

Sequence variation in enhancers that control cell type-specific gene transcription contributes significantly to phenotypic variation within human populations. However, it remains difficult to predict precisely the effect of any given sequence variant on enhancer function due to the complexity of DNA sequence motifs that determine transcription factor (TF) binding to enhancers in their native genomic context. Using F1-hybrid cells derived from crosses between distantly related inbred strains of mice, we identified thousands of enhancers with allele-specific TF binding and/or activity. We find that genetic variants located within the central region of enhancers are most likely to alter TF binding and enhancer activity. We observe that the AP-1 family of TFs (Fos/Jun) are frequently required for binding of TEAD TFs and for enhancer function. However, many sequence variants outside of core motifs for AP-1 and TEAD also impact enhancer function, including sequences flanking core TF motifs and AP-1 half sites. Taken together, these data represent one of the most comprehensive assessments of allele-specific TF binding and enhancer function to date and reveal how sequence changes at enhancers alter their function across evolutionary timescales.

Data availability

We submitted our data to GEO, and it is now accessible via GSE193728.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Marty G Yang

    Department of Neurobiology, Harvard University, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Emi Ling

    Department of Neurobiology, Harvard University, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5287-0284
  3. Christopher J Cowley

    Laboratory of Mammalian Cell Biology and Development, Rockefeller University, Howard Hughes Medical Institute, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Michael E Greenberg

    Department of Neurobiology, Harvard University, Boston, United States
    For correspondence
    meg@hms.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
  5. Thomas Vierbuchen

    Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States
    For correspondence
    vierbuct@mskcc.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5690-5680

Funding

NIH Office of the Director (T32EY00711030)

  • Marty G Yang

NIH Office of the Director (T32AG000222)

  • Marty G Yang

National Science Foundation (DGE0946799)

  • Emi Ling

National Science Foundation (DGE1144152)

  • Emi Ling

NIH Office of the Director (R01 NS115965)

  • Michael E Greenberg

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments were approved by the National Institutes of Health and the Harvard Medical School Institutional Animal Care and Use Committee and were conducted in compliance with the relevant ethical regulations (Protocol # IS00000074-3)

Copyright

© 2022, Yang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,995
    views
  • 526
    downloads
  • 13
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marty G Yang
  2. Emi Ling
  3. Christopher J Cowley
  4. Michael E Greenberg
  5. Thomas Vierbuchen
(2022)
Characterization of sequence determinants of enhancer function using natural genetic variation
eLife 11:e76500.
https://doi.org/10.7554/eLife.76500

Share this article

https://doi.org/10.7554/eLife.76500

Further reading

    1. Chromosomes and Gene Expression
    Shihui Chen, Carolyn Marie Phillips
    Research Article

    RNA interference (RNAi) is a conserved pathway that utilizes Argonaute proteins and their associated small RNAs to exert gene regulatory function on complementary transcripts. While the majority of germline-expressed RNAi proteins reside in perinuclear germ granules, it is unknown whether and how RNAi pathways are spatially organized in other cell types. Here, we find that the small RNA biogenesis machinery is spatially and temporally organized during Caenorhabditis elegans embryogenesis. Specifically, the RNAi factor, SIMR-1, forms visible concentrates during mid-embryogenesis that contain an RNA-dependent RNA polymerase, a poly-UG polymerase, and the unloaded nuclear Argonaute protein, NRDE-3. Curiously, coincident with the appearance of the SIMR granules, the small RNAs bound to NRDE-3 switch from predominantly CSR-class 22G-RNAs to ERGO-dependent 22G-RNAs. NRDE-3 binds ERGO-dependent 22G-RNAs in the somatic cells of larvae and adults to silence ERGO-target genes; here we further demonstrate that NRDE-3-bound, CSR-class 22G-RNAs repress transcription in oocytes. Thus, our study defines two separable roles for NRDE-3, targeting germline-expressed genes during oogenesis to promote global transcriptional repression, and switching during embryogenesis to repress recently duplicated genes and retrotransposons in somatic cells, highlighting the plasticity of Argonaute proteins and the need for more precise temporal characterization of Argonaute-small RNA interactions.

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Steven Henikoff, David L Levens
    Insight

    A new method for mapping torsion provides insights into the ways that the genome responds to the torsion generated by RNA polymerase II.